Moderna applies for full FDA approval of its COVID-19 vaccine
If approved the vaccine will stay on U.S. markets after the pandemic is over.
The Facts Inside Our Reporter’s Notebook
Moderna on Monday asked the Food and Drug Administration for full approval of its COVID-19 vaccine.
The move makes Moderna the second U.S. drugmaker to seek a biologics license that will allow it to market the shots directly to customers, according to CNBC.
Full approval will allow the vaccine to stay on the U.S. market once the pandemic is over.
News, Not Noise
- Georgia investigator's notes reveal 'massive' election integrity problems in Atlanta
- Over 7,000 affidavits delivered to Michigan lawmakers claim election fraud
- Georgia audit documents expose significant election failures in state's largest county
- GOP lawmakers to Biden: 'We write to you today to express concern with your current cognitive state'
- Pelosi says GOP wants people 'in cars, on the road, using gas,' Dems want more mass transit